Cardiac risk stratification is a critical process in assessing an individual's likelihood of developing cardiovascular complications and tailoring appropriate preventive measures. This method involves the systematic evaluation of various risk factors that contribute to heart-related issues, such as age, gender, family history, smoking habits, blood pressure, cholesterol levels, and existing medical conditions. By analyzing these factors, healthcare professionals can categorize individuals into different risk groups, ranging from low to high risk. This stratification enables the development of personalized intervention plans, including lifestyle modifications, medication, and regular monitoring, to mitigate the potential for cardiac events. Accurate risk assessment is instrumental in enhancing early detection and intervention, ultimately improving patient outcomes and reducing the overall burden of cardiovascular diseases. Regular updates to risk stratification guidelines ensure that healthcare providers stay abreast of the latest research and technological advancements, refining their ability to predict and manage cardiac risks effectively.
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile